Status:
COMPLETED
A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Conditions:
Parkinson's Disease
Malignant Melanoma
Eligibility:
All Genders
Brief Summary
Patients with Parkinson's disease will be seen by a dermatologist who will biopsy any suspicious skin lesions.
Eligibility Criteria
Inclusion
- Confirmed diagnosis Parkinson's disease Patient able and willing to give informed consent Patient must not be taking any investigational drug at the time of enrollment
Exclusion
- unconfirmed, undocumented Parkinson's disease unable to give consent taking any investigational product
Key Trial Info
Start Date :
January 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2003
Estimated Enrollment :
2106 Patients enrolled
Trial Details
Trial ID
NCT00203008
Start Date
January 1 2003
End Date
September 1 2003
Last Update
October 18 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.